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Dentin sialoprotein (DSP) and phosphophoryn (PP) are two major dentin noncollagenous proteins that are encoded on a single DSP–PP
transcript whose expression is tightly regulated during tooth dentinogenesis. The recent identification of this gene transcript in other tissues,
including inner ear and jaw tissue, suggests that DSP and PP may have pleiotropic effects on other organs besides teeth. To identify candidate
regulatory elements that control DSP–PP temporal and spatial expression, we constructed a 5 kb upstream region rat DSP–PP promoter into the
h-galactosidase expression vector pnLacF plasmid and used this construct to prepare DSP–PP-LacZ transgenic mice. Multiple mouse tissues
including teeth, bone, and kidney obtained from the six resulting transgenic mouse lines displayed strong LacZ activity. This spatial distribution
was confirmed in several of these tissues by in situ hybridization studies. LacZ activity was transiently expressed in preameloblasts and
continuously expressed in odontoblasts demonstrating that this 5 kb rat promoter-dependent LacZ expression mimics reported DSP–PP mRNA
expression patterns. Interestingly, this 5 kb rat promoter construct drives LacZ expression according to the rat developmental clock. Based on
identified transcription factors present in this 5 kb promoter region, we have identified several probable cis-regulatory modules whose
interaction with one another could account for the spatial and temporal distribution of DSP–PP transcripts in developing tissues.
D 2005 Elsevier Inc. All rights reserved.Keywords: Rat DSP–PP promoter; LacZ activity; cis-elements; Developmental clock; Tooth; Bone; KidneyIntroduction
The genetic pathways governing the development of the tooth
as an organ are strictly controlled by an ordered series of
appropriately timed reciprocal epithelial–mesenchymal interac-
tions requiring multiple growth and transcription factors
(Thesleff, 1991; Aberg et al., 1997; Jernvall and Thesleff,
2000). For example, transcription factors BMP4, Msx1, and
Cbfa1 each exhibit unique temporal and spatial expression
patterns during different tooth developmental stages (Jernvall
and Thesleff, 2000). A point mutation in Msx1 has been linked
to the autosomal dominant agenesis of second premolars and0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Institute, Buffalo, NY, USA.third molars (Vastardis et al., 1996). Msx1 knockout mice have
no teeth (Satokata andMaas, 1994). Cbfa1 is expressed in dental
mesenchymes but not in mature odontoblasts expressing intense
DSP–PP mRNA. Cbfa1 knockout mice showed arrested tooth
development during cap and early bell stages (D’Souza et al.,
1999). Nevertheless, when properly functioning, these tran-
scription factors enable the transcription of appropriate dentin-
related noncollagenous proteins (NCPs) required for orderly
dentin mineralization.
Two major noncollagenous proteins, dentin sialoprotein
(DSP) and phosphophoryn (PP), derived from a single DSP–
PP transcript (also known as DSPP), are required for proper
dentinogenesis. In situ hybridization studies have clearly
shown that DSP–PP mRNA is transiently expressed in
preameloblasts and is also found in differentiating and mature
odontoblasts (D’Souza et al., 1997; Ritchie et al., 1997;
Begue-Kirn et al., 1998a,b). The DSP–PP gene was mapped
to human chromosome 4q21.3 and to mouse chromosome89 (2006) 507 – 516
www.e
V. Godovikova et al. / Developmental Biology 289 (2006) 507–5165085q21 (George et al., 1996; Feng et al., 1998). The genetic
architecture of the DSP–PP gene includes 5 exons and 4
introns: exons 1–4 encode DSP, whereas exon 5 encodes the
carboxyl terminus for DSP and the complete PP transcript
(Ritchie et al., 1994; Ritchie and Wang, 1996; MacDougall et
al., 1997; Ritchie and Wang, 1997; Ritchie et al., 1998).
Dentinogenesis imperfecta II, an autosomal dominant
disorder causing dentin hypo-mineralization and significant
tooth decay, has been linked to a nonsense mutation located
in the coding sequence for human DSP that is likely
responsible for blocking both DSP and PP expression (Zhang
et al., 2001). More recently, several additional mutations in the
DSP–PP gene have also been linked to this genetic disease
(Rajpar et al., 2002; Kim et al., 2004; Malmgren et al., 2004).
Interestingly, DGI patients also suffer from progressive hearing
loss (Xiao et al., 2001) suggesting that DSP–PP may have a
pleiotropic effect on other organs besides teeth. Reverse
transcription-PCR studies by Xiao et al. (2001) suggest that
DSP–PP mRNA is also expressed in inner ears and jaw tissues.
DSP protein and DSP–PP transcripts have also now been
identified in bone cells, bone matrix (Qin et al., 2002, 2003)
and in rat periodontium (Baba et al., 2004). Taken together,
these studies suggest that DSP–PP mRNA might actually be
present in a broad range of tissues and thus DSP–PP may
participate in additional developmental activities.
Comparative analysis of cross-species genomic sequences
(100 bp in length) that are highly conserved among
mammals (70% identity) has proven to be an effective
approach for identifying distant gene regulatory sequences
(Hardison et al., 1997; Li et al., 1999). For example, Loots et
al. (2000) identified a coordinate regulator of interleukins 4,
13, and 5 by cross-species sequence comparison. To identify
candidate regulatory elements that control DSP–PP temporal
and spatial expression, we compared the upstream sequences
from the DSP–PP transcription start sites among mouse, rat,
and human sequences (Ritchie et al., 2002). Using Vista Plot
analysis, we identified a 500 bp highly conserved noncoding
sequence. Within this 500 bp sequence, we found a TTTAAA
box and DNA sequence target sites for transcription factors
such as C/EBP, Msx-1, SRE, NF-Kb, AP1, and -TFIID.EIIa
(Ritchie et al., 2002). This conserved 500 bp region therefore
appeared to be a likely candidate to search for DSP–PP
regulatory elements. However, several additional Msx1
binding sites were identified in the 5V upstream flanking
region (i.e., at 5 kb, 1.5 kb, and 1 kb from the
transcriptional start site) and several Cbfa1 binding sites were
also identified in the 5V upstream flanking region (i.e., at 5
kb and 2.5 kb) (Ritchie unpublished data). Thus, besides the
conserved 500 bp region, other genomic regions may also
be important in controlling DSP–PP mRNA expression.
To better understand the molecular mechanisms responsi-
ble for the regulation of DSP–PP gene expression, we
created a rat 8 kb construct, comprising a 5 kb upstream
DSP–PP promoter, an exon1–intron1 sequence, and a LacZ
gene construct (hereinafter ‘‘5 kb rat promoter’’), to test
DSP–PP promoter-directed LacZ activity in transgenic mice.
Previously reported transgenic studies included a 3.8 kb ratDSP–PP promoter construct and a 6 kb mouse DSP–PP
promoter construct. Yamazaki et al. (1999), using a 3.8 kb rat
construct comprising a 420 bp DSP–PP promoter-exon1–
intron1–LacZ gene (hereinafter ‘‘420 bp rat promoter’’)
showed weak LacZ activity in transgenic mice and the LacZ
activity was limited only to tooth odontoblasts. In another study
by Sreenath et al. (1999), a 6 kb mouse construct comprising a
2.4 kb mouse DSP–PP promoter–exon1–intron1–exon2–
LacZ gene (hereinafter ‘‘2.4 kb mouse promoter’’) drove
strong LacZ expression in both odontoblasts and secretory
ameloblasts. However, the LacZ expression pattern in preame-
loblasts and odontoblasts was differed from those found in wild-
type mice (D’Souza et al., 1997; Ritchie et al., 1997; Begue-Kirn
et al., 1998a,b). Apparently, the promoter constructs used by
these investigators did not contain sufficient information to
enable correct spatial or temporal LacZ expression patterns
during dentinogenesis.
We report here on the spatial and temporal LacZ activity
profiles from transgenic mice carrying the 5 kb rat
promoter construct. We find that this promoter construct
drives LacZ expression in preameloblasts and odontoblasts,
and closely mimics the DSP–PP mRNA expression pattern
found in wild-type mice. Moreover, LacZ activity was
detected in multiple tissues including teeth, bone, and kidney
suggesting that DSP and PP are multifunctional proteins.
Interestingly, this 5 kb rat promoter construct drives LacZ
expression according to the rat developmental clock (i.e.,
expression is delayed by 2 days) rather than by the mouse
developmental clock. This 5 kb rat promoter construct
should provide a useful tool for discovering potential cis-
regulatory modules that regulate temporal and spatial LacZ
expression in a wide variety of tissues.
Materials and methods
Construction of a 5 kb 5VDSP–PP gene flanking region into the
b-galactosidase expression vector pnLacF plasmid
A rat genomic clone containing a 14 kb insert was isolated from a
lambda-dash rat genomic library with 32P-DSP cDNA (Ritchie et al., 2001).
This genomic clone contains a 5 kb upstream DNA flanking sequence
from the transcription start site, 5 exons and 4 introns as shown in Fig. 1A.
Through a series of constructions from the genomic clone, we isolated and
inserted an 8.4 kb DSP–PP promoter DNA fragment into a pnLacF vector
at restriction enzyme SalI site (see Fig. 1B). An ¨8 kb DSP–PP promoter–
LacZ construct which contained a 5 kb upstream DNA flanking sequence,
exon1, and the full 3.3 kb intron1 (hereinafter ‘‘5 kb rat promoter’’) was
then prepared by removing the vector sequence (see Fig. 1C). The pnLacF
vector, kindly provided by Dr. Richard Palmiter, contained an E. coli LacZ
gene modified at the amino terminus to encode the SV40 T antigen nuclear
localization signal (Mercer et al., 1991).
Transgenic mouse generation, identification, and breeding
The DSP–PP-LacZ transgene was microinjected into fertilized eggs
obtained by mating (C57BL/6J  SJL/J)F1 mice. The pronuclei of these eggs
were then injected with approximately 2 pl of DNA (1–2 ng/Al). The eggs were
transferred to pseudopregnant (C57BL/6  DBA/2)F1 recipients. Fourteen
transgenic founders were identified among 41 mice born. The 5 kb DSP–
PP–exon1– intron1–hgal transgenic founders were mated to C57BL/6J mice
to generate transgenic offspring for analysis of LacZ expression.
Fig. 1. A 5 kb rat DSP–PP promoter construct. (A) The genomic rat DSP–PP gene is comprised of five exons (i.e., E1, E2, E3, E4, and E5) and four introns. An
¨8 kb DNA fragment, containing a 5 kb upstream flanking sequence, exon 1, and a 3.3 kb intron 1 was used to generate the DSP–PP promoter construct. (B) A
diagram of the h-galactosidase expression vector pnLacF plasmid. The ¨8 kb DNA fragment was inserted into the pnLacF plasmid at the SalI site. mp1: mouse
protamine 1 sequence. (C) A diagram of the 5 kb rat DSP–PP promoter construct. This 5 kb rat DSP–PP promoter construct is comprised of a 5 kb upstream
flanking sequence, exon 1, a 3.3 kb intron 1 and a LacZ gene. After separation from the vector DNA sequence, this construct was used for generating transgenic
mice. represents the transcription start site.
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Animals were euthanized at 17 days postcoitum and 1, 3, 5, 14 days
postnatal and processed for cryostat sections. Fresh samples from transgenic
whole embryos, neonatal mice, head, and body sections were processed by
cryosection. LacZ activity was detected by staining of frozen sections (12 Am)
with X-gal (5-bromo-4-chloro-3-indoly-h-d-galactopyranoside; Boehringer-
Mannheim) (Saunders, 2003). Slides were fixed for 5 min with 0.2%
glutaraldehyde, 5 mM EGTA, 2 mM MgCl2 in 0.1 M sodium phosphate
buffer at pH 7.3. They were then washed three times for 5 min each with a rinse
solution containing 2 mMMgCl2, 0.2% NP-40, and 0.1% sodium deoxycholate
in 0.1 M sodium phosphate buffer at pH 7.3. Staining was performed in the
dark at 37-C overnight in the rinse solution supplemented with 1 mg/ml X-gal,
5 mM potassium ferrocyanide, and 5 mM potassium ferricyanide. After
staining, the slides were washed with PBS and counterstained with 1% neutral
red or 1% eosin to indicate morphology. The pattern of LacZ expression was
examined by a Nikon Eclipse E400 light microscopy and photographed with a
Spot Real Time camera. The LacZ expression patterns that we observed were
consistent between 4 of the 6 transgenic lines. The other two lines gave little or
no LacZ expression.
In situ hybridization
Templates for antisense and sense riboprobes for DSP–PP gene were
generated by digesting DSP–PP523 cDNAwith appropriate restriction enzymes
and an in vitro transcription assay was carried out to incorporate digoxigenin-
11-dUTR with T7 and Sp6 RNA polymerases according to standard
manufacture’s protocol (Roche Diagnostics, Indianapolis, IN). Dewaxed
paraffin sections as well as frozen sections (12 Am) were fixed with 4%
paraformaldehyde (PFA) in PBS buffer. After treatment with proteinase K (10
Ag/ml) for 10 min, the paraffin sections were postfixed in 4% PFA for 5 minand dipped in 0.1 M triethanolamine containing 0.25% acetic anhydride for 15
min. Hybridization was performed at 50-C using denatured antisense or sense
riboprobe in hybridization buffer (40% formamide, 5 SSC, 1 Denhardt’s
solution, 100 Ag/ml salmon DNA, 100 Ag/ml yeast tRNA) for 20 h. After
posthybridization treatments, including RNase A treatment (10 Ag/ml, 24 min,
37-C) followed by thorough washes, the sections were reacted with
antidigoxigenin antibody conjugated with alkaline phosphatase (1:1000) and
stained with NTB/BCIP solution (Roche, Indianapolis, IN). Sections were
observed and photographed with a Nikon Eclipse E400 light microscopy and a
Spot Real Time camera.
Results
Rat 5 kb DSP–PP promoter drives LacZ activity in mouse
teeth
Incisors
To examine the effectiveness of our 5 kb rat promoter in
directing LacZ expression during tooth development in our
transgenic mice, we systematically examined LacZ activity in
mouse incisors at various developmental stages. No LacZ
staining was detected in sagittal sections from day 3 wild-type
mice (Fig. 2A). However, LacZ activity was detected in day 3
transgenic maxillary and mandible incisors (Fig. 2B). No LacZ
activity was revealed in incisors from embryonic day 17 (not
shown) or newborn transgenic mice (Fig. 2C). In newborn
transgenic mice, LacZ expression was present in the area where
the alveolar bone surrounds the maxillary incisor primordium
Fig. 2. Rat DSP–PP promoter-driven LacZ activity in incisor and molars obtained from transgenic mice. LacZ activity in tissue sections from transgenic mice
containing the 5 kb rat promoter construct was visualized using X-gal as described in Methods. LacZ staining is presented in photos A, B, C, D, E, F1, G, and H.
Neutral Red was used for counter-staining in photos A, B, C, D, and G. Eosin was used for counter-staining in photos E and F1. DIG staining for in situ hybridization
studies was performed in F2. Photos A–G represent LacZ staining in mouse incisors. (A) Sagittal section from day 3 wild-type mouse head. (B) Sagittal section from
day 3 transgenic mouse head. (C) Maxillary incisor section from newborn transgenic mouse. Scale: 4 magnification. (D) Maxillary incisor section from postnatal
day 2 transgenic mouse. Scale: 4 magnification. (E) Maxillary incisor section from postnatal day 3 transgenic mice. Scale: 4 magnification. (F1) High
magnification of photo E. (F2) In situ studies with DIG-labeled DSP–PP523 antisense riboprobe in day 3 maxillary incisor section from transgenic mice. Scale: 40
magnification. (G) Mandible incisor section from postnatal day 14 transgenic mice. Scale: 4 magnification. Photos H–K represent LacZ staining in mouse molars.
(H) Newborn transgenic mouse molar. The section was counter-stained with neutral red. Scale: 4 magnification. (I) LacZ staining in postnatal day 3 transgenic
mice and counter-stained with eosin. Scale: 4 magnification. (J) High magnification of photo I. Scale: 20. (K) LacZ staining in 2nd and 3rd molars in postnatal
day 14 transgenic mice. Scale: 4 magnification. Arrow represents incisor. Arrowhead signifies alveolar bone. dp: dental pulp. od: odontoblasts. pa: preameloblasts.
a: ameloblasts. Scale bar: 100 Am.
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transgenic mice in the apical end of the odontoblast layer in the
maxillary incisors (Fig. 2D). In postnatal day 3 transgenic
mice, we observed stronger odontoblast LacZ staining (Fig.
2E). For comparison, we performed in situ hybridization
studies in postnatal day 3 maxillary incisors using a DIG-
labeled DSP–PP523 antisense probe. DSP–PP mRNA expres-
sion was also present in odontoblasts (Fig. 2F2). Moreover, the
promoter-directed LacZ expression was superimposed on the
endogenous DSP–PP mRNA profile (Figs. 2F1 vs. F2). Finally,
postnatal day 14 transgenic mice exhibited weak LacZ activity
in dental pulp along with strong LacZ staining in preamelo-
blasts and in odontoblasts demonstrating transient develop-
mental expression (Fig. 2G).
Molars
We next tested the effectiveness of our 5 kb rat promoter
in directing LacZ expression in developing molars. No LacZ
staining was detected in first molars obtained from newborn
transgenic mice (Fig. 2H) even though DSP–PP mRNA has
reportedly been expressed in newborn mouse first molar teeth
(D’Souza et al., 1997; Ritchie et al., 1997). LacZ activity began
to be expressed in first molar teeth from postnatal day 3transgenic mice (Figs. 2I, J). No LacZ activity was observed in
second molar teeth (not shown) yet endogenous DSP–PP
mRNA was reported to be present in the first and second
molars in postnatal day 3 wild-type mice (D’Souza et al.,
1997). In postnatal day 14 transgenic mice, LacZ activity was
detected in the first (not shown), second, and third molars from
postnatal day 14 mice (Fig. 2K).
Rat 5 kb DSP–PP promoter drives LacZ activity in other
mouse tissues
Alveolar bone
Tissue sections showing LacZ activity in areas where
alveolar bones surround the maxillary incisor and molar
primordium were obtained from newborn transgenic mice
(Figs. 3A1, A2). LacZ activity was detected in the alveolar
bone surrounding the incisors (Fig. 2G). Control sections
obtained from the same areas in postnatal day 3 wild-type
mice showed no LacZ activity (Figs. 3B1, B2). To further
validate this finding, a tissue section from postnatal day 6
wild-type rat tooth jaw tissue was subjected to in situ
hybridization using a rat DIG-labeled DSP–PP523 antisense
riboprobe. Fig. 3C represents a bright field photograph of
Fig. 3. Rat DSP–PP promoter-driven LacZ activity in alveolar bones, endochondral bones, and kidney obtained from transgenic mice. Photos A–D represent LacZ
activity in alveolar bone surrounding the incisors and molars. Neutral red was used as a counter-staining. (A1) Alveolar bones surround the maxillary incisor
primordium from newborn transgenic mouse. Scale: 40. (A2) Alveolar bones surround the maxillary molar primordium in newborn transgenic mouse. Scale: 40.
(B1) Alveolar bones surround the maxillary incisor from postnatal day 3 wild-type mouse. Scale: 40. (B1) Alveolar bones surround the maxillary molar from
postnatal day 3 wild-type mouse. Scale: 40. (C) Bright field photograph of postnatal day 6 wild-type rat first molar and the surrounding alveolar bone. Scale: 20.
(D) DIG-labeled DSP–PP523 antisense riboprobe staining. Od: odontoblasts. PA: preameloblasts. Arrow represents osteoblast on alveolar bone. Scale: 20. Inserted
box at the right upper corner represents enlarged alveolar bone and osteoblasts. b: bone. White arrow-head stands for osteoblasts. Photos E–J represent LacZ activity
in bone. Neutral red was used for counter-staining. ‘‘C’’ stands for cartilage. (E) Rib in postnatal day 3 transgenic mouse. (F) Rib in postnatal day 3 wild-type mouse.
(G) Vertebrae in postnatal day 3 transgenic mice. Scale: 10. (H) Vertebrae in postnatal day 3 wild-type mouse. Scale: 10. (I) Basioccipital bone in postnatal day 5
transgenic mouse. (J) Basioccipital bone in postnatal day 6 wild-type mouse. Scale: 10. Photos K–N represent LacZ activity in long bones. Eosin was used for
counter-staining. ‘‘C’’ stands for cartilage. (K) Joint part of femur bone in postnatal day 14 transgenic mouse. Scale: 10. (L) High magnification of femur bone.
Scale: 40. (M) The head of the tibia bone in postnatal day 14 transgenic mouse. Scale: 10. (N) The head of the tibia bone in postnatal day 6 wild-type mouse.
Scale: 10. Photos O–P represent LacZ activity in kidney. Neural Red was used for counter-staining. (O) Kidney in postnatal day 3 transgenic mouse. Scale: 4. (P)
Kidney in postnatal day 3 wild-type mouse. Scale: 4. Scale bar: 100 Am.
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alveolar bone. Fig. 3D clearly demonstrates DIG-staining in
osteoblasts in alveolar bone, odontoblasts, and preamelo-
blasts. This rat antisense riboprobe result further confirms our
mouse LacZ results demonstrating that DSP–PP mRNA is
expressed in alveolar bone.
Basioccipital bone
LacZ activity was detected in basioccipital bone (Fig. 3I) in
postnatal day 5 transgenic mice. In this tissue section, cartilage
is stained with neutral red and LacZ staining appears in cells
subjacent to the cartilage where ossification occurs. Similar
sections obtained from postnatal day 6 wild-type mice, but
stained with eosin, showed weak LacZ staining in trabecular
bone distal to the cartilage (Fig. 3J).Inner ear
Some positive LacZ staining was detected in temporal bones
surrounding inner ear (not shown).
Skeletal bones: rib, vertebrae, and limb
Tissue sections were also obtained from rib and vertebrae
areas from postnatal day 3 transgenic mice. LacZ activity was
present in both rib (Fig. 3E) and vertebrae (Fig. 3G) sections,
but no LacZ activity was visible in rib (Fig. 3F) or vertebrae
(Fig. 3H) sections obtained from similarly aged wild-type
mice.
LacZ staining was also detected in sternum, scapula, and
humerus (not shown). In postnatal day 14 transgenic mice,
LacZ activity was detected in the talus bone and the stained
cells were aligned along the ossification site (Fig. 3K). Fig. 3L
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shows LacZ positive cells in the femur in day 14 transgenic
mice. These LacZ positive cells were mainly positioned
subjacent to cartilage in the ossification region (Figs. 3K–
M). In the wild-type mice, weaker LacZ activity was detected
in the femur but the LacZ positive cells were positioned at
some distance from the cartilage (Fig. 3N).
Cartilage
As shown above (see Basioccipital bone and Skeletal bones:
rib, vertebrae and limb), LacZ activity was prominently
expressed in cells subjacent to cartilage (Fig. 3E). Within the
neutral red stained cartilage, some darkly blue stained cells
suggesting the possible presence of chondrocytes with LacZ
activity were also observed. To further examine this possibility,
we stained additional tissue sections with eosin (Figs. 3K–M).
Here, chondrocytes were stained weakly with eosin and no
LacZ activity was detected.
Kidney
LacZ activity was observed in tissue sections of kidney
cortex in postnatal day 3 transgenic mice. No LacZ activity was
present in the corresponding wild-type mice (Figs. 3O vs. P).
Intestine
LacZ activity was observed in intestine sections for both
wild-type and transgenic mice. Thus, LacZ activity in intestine
is not promoter-specific.
Other tissues
No LacZ activity was observed in tissue sections obtained
from aorta, brain, cerebellum, spinal cord, parathyroid, heart,
liver, lung, muscle, pancreas, salivary gland, spleen, bladder,
stomach, and testis.
Discussion
Our 5 kb promoter-driven LacZ tissue expression patterns
mimic many of the endogenous DSP–PP expression patterns
reported by Ritchie et al. (1997) and by D’Souza et al. (1997).
For example, during development in wild-type rats, DSP–PP
mRNA is first expressed in preameloblasts, then in both
preameloblasts and odontoblasts within a narrow time window,
after which DSP–PP mRNA is only expressed in odontoblasts
(Ritchie et al., 1997). Our rat promoter directed LacZ
expression in both preameloblasts and in odontoblasts in
postnatal day 14 transgenic mice. In addition to correctly
directing lacZ expression in teeth, our 5 kb rat promoter was
also able to direct LacZ expression in a wide variety of
heretofore-unidentified tissues including alveolar bone, rib,
vertebrate, long bone, and kidney. Earlier studies, using shorter
promoter constructs, reported restricted LacZ tissue expression.
For example, Yamazaki et al. (1999) using a 420 bp rat
promoter, reported that their rat promoter driven galactosidase
activity was weakly expressed and restricted exclusively to
odontoblast lineage cells. Another study by Sreenath et al.
(1999) reported that a 2.4 kb mouse promoter drove stronggalactosidase expression in odontoblasts prior to appearing in
secretory ameloblasts. This expression pattern is different from
that of endogenous DSP–PP transcripts in vivo where, in rat
incisor and rat molar tooth for example, the DSP–PP transcript
was transiently expressed first in the preameloblasts and later in
odontoblasts (D’Souza et al., 1997; Ritchie et al., 1997; Hao et
al., 2004). It is possible that these two promoters were
unresponsive to endogenous enhancers because of their
truncated nature and thus unable to correctly mimic wild-type
temporal or spatial expression patterns.
Our in situ data (see Fig. 3D) demonstrating DSP–PP
mRNA expression in wild-type mouse alveolar bone validate
our current finding that LacZ activity was present in alveolar
bone obtained from transgenic mice. Additionally, LacZ
activity was found in ribs, vertebrae, and long bone (Fig. 3).
These bones are formed by endochondral ossification and the
LacZ positive cells were aligned close to the cartilage in the
ossification regions. As shown in Figs. 3K and L, these LacZ
positive cells are likely osteoblasts. Mishina et al. (2004)
reported an osteoblast-specific promoter-directed LacZ activity
in cells aligned with the cartilage. Butler and co-workers, using
Western blots and reverse transcription-PCR, detected the
presence of DSP protein in long bone and DSP–PP mRNA in
calvaria (Qin et al., 2002, 2003). They also used immunohis-
tochemistry and in situ hybridization to localize DSP protein
and DSP–PP mRNA in alveolar bone osteoblasts (Baba et al.,
2004). In older wild-type mice, weak LacZ activity was found
in endochondral bone but the activity distribution differed from
that found in our transgenic animals (wild-type: Figs. 3J, N vs.
transgenic: Figs. 3I, K, L, M). The detection of LacZ activity
was also reported in osteoblasts of wild-type mice (Komarova
et al., 1997). However, endogenous LacZ activity in osteoblasts
was much weaker compared to that of transgenic mice with
p53-responsive LacZ (Komarova et al., 1997). Thus, we
conclude that our 5 kb rat promoter is also able to direct
LacZ expression in alveolar and endochrondral bones.
We identified LacZ positive cells in kidney sections
obtained from our transgenic mice suggesting that DSP–PP
mRNA is also expressed in kidney (Fig. 3O). DSP–PP belongs
to the small integrin-binding ligand N-linked glycoprotein
(SIBLING) family of proteins involved in regulating the
mineralization of extracellular matrix. This family of proteins
includes BSP, OPN, dentin matrix protein 1 (DMP1), and
matrix extracellular phosphoglycoprotein (MEPE) (Fisher and
Fedarko, 2003). Recently, Quarles (2003) questioned whether
two novel phosphatonins that regulate systemic phosphate
homeostasis act independently or are somehow integrated in a
phosphate-regulating bone–kidney axis. OPN and Dmp1,
major bone proteins along with MEPE, are also found in
kidney (McKee et al., 1995; Umekawa et al., 1995; Rowe et al.,
2000; Terasawa et al., 2004).
Why is DSP–PP mRNA expressed in so many tissues?
SIBLING proteins may have functions other than direct control
of tissue mineralization. For example, BSP, OPN, and DMP1
bind with high affinity (nM) to matrix metalloproteinases
(MMPs) and activate MMPs in vitro. This may initiate a
SIBLING–MMP activation pathway in vivo (Fedarko et al.,
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bones, SIBLING–MMP complexes could participate in protein
processing needed for proper maturation of tissue matrix
environments prior to mineralization. Our results describing
DSP–PP promoter-driven LacZ activity provide ample impetus
for future studies designed to better define DSP–PP–MMP
interactions and their ability to affect tissue mineralization and
development.
Our 5 kb rat promoter results further suggest that this
construct will become a useful tool to discover potential cis-
elements that regulate DSP–PP temporal expression patterns.
Previous in situ studies by our group and by others indicated
that DSP–PP mRNA began to be expressed in newborn first
molars, but not in second molars, in both rat and mouse
(D’Souza et al., 1997; Ritchie et al., 1997; Hao et al., 2004).
Using a rat 420 bp DSP–PP promoter construct, Yamazaki et
al. (1999) demonstrated that this promoter was able to drive
LacZ expression in postnatal day 1 molars derived from
transgenic mice. However, in our transgenic studies, no LacZ
staining was detected in first molars obtained from newborn
mice (Fig. 2H). LacZ activity began to be expressed in the first
molar teeth from postnatal day 3 transgenic mice (Figs. 2I, J)
but no LacZ activity was observed in second molar teeth from
these mice. Because rat embryo development lags mouse
embryo development by 2 days (Altman and Dittmer, 1962),
this observation suggests that the 5 kb upstream region DSP–
PP rat promoter directs DSP–PP mRNA expression according
to the rat developmental clock instead of the mouse develop-
mental clock. Earlier studies involving the transplantation of
fetal cells into adult animals lend support to our results in that
they demonstrated that the donor cells retained their fetal
gestational clocks (Wood et al., 1985). It is therefore likely that
the DNA sequence responsible for DSP–PP temporal expres-
sion is located within the 5 kb to 420 bp upstream region of
the rat DSP–PP promoter.
Further analysis of the 500 bp conserved noncoding
sequence provides additional insight into potential DSP–PP
promoter transcriptional regulatory sites. Ritchie and co-workers
earlier identified a rat 405 bp-luciferase construct that could
drive a strong luciferase activity in mouseMDPC-23 dental pulp
cells and in rat MRPC-1 dental pulp cells (Ritchie et al., 2002;
Ritchie, unpublished data). Within this conserved sequence, we
identified a conserved Y box at 52 bp and demonstrated that a
CCAAT-binding nuclear protein extract was sequence-specific.
We suggested that the CCAAT binding site is likely involved in
binding transcription factor C/EBPs and in regulating DSP–PP
transcription activities (Ritchie et al., 2002). Chen et al. (2004)
using a MO6-G3 mouse cell line and 95 bp and 241 bp
DSP–PP promoter–luciferase constructs, found that mutations
in CCAAT site resulted in a 5-fold decrease in DSP–PP
promoter activity. Since CCAAT-binding factor (CBF; also
termed NF-Y and CP1) is known to interact with other
transcription factors or co-activators to activate or regulate gene
expression, these data indicate that the CBF binding site
enhances mouse DSP–PP promoter activity in mouse dental
pulp cells. Chen and co-workers further identified a novel
protein–DNA binding site (ACCCCCA) that was located nearan inverted CCAATsite. The abolishment of the ACCCCCA site
led to a 4.5-fold increase in promoter activity suggesting that the
ACCCCCA cis-element and its binding protein participate in
suppressing DSP–PP expression. Because the inhibitory effect
caused by the ACCCCCA site was influenced by a CCAAT
mutation, CBF and the ACCCCCA binding protein most likely
work together to influence DSP–PP promoter activity.
Other synergistic transcription protein pairings are also
apparent in the DSP–PP promoter. Using several DSP–PP
promoter-luciferase constructs and a hTERT-immortalized rat
dental pulp cell line, Narayanan et al. (2004) found that C/EBP
could repress a promoter that contained a mutated Nrf1 site, yet
Nfr1 could not repress a promoter that contained a mutated C/
EBP binding site. In the same paper, they also reported that while
the two transcription factors, located at positions 90 and 71,
acted together to suppress DSP–PP mRNA expression in a
700 bp promoter, the addition of these two transcription factors
to a 400 bp promoter failed to suppress DSP–PP mRNA
expression. Thus, another cis-regulatory element(s), possibly
located between 700 bp and400 bp, may also be required to
interact with the DNA sequences containing the CAATT and
Nrf1 binding sites to down-regulate DSP–PP gene expression.
Taken together, these results support a model regulatory
system proposed by Davidson et al., in which ‘‘cis-regulatory
modules’’ of 300 bp or more each contain 10 or more
transcription binding sites (Davidson et al., 2002; Davidson et
al., 2003). Their model further proposed that a particular cis-
regulatory module produces a specific pattern of gene expres-
sion in space or time and that multiple modules can produce
complex gene expression patterns. As shown in Figs. 4A–C, the
5 kb DSP–PP promoter construct contains many cis-elements
(i.e., CBF, Msx1, and Cbfa 1, etc.) that can serve as target sites
for transcription factors acting through a variety of cis-
regulatory modules. Thus, one potential DSP–PP cis-regulatory
module may comprise the DNA sequence between420 bp and
31 bp. This module probably acts through the basal promoter
(i.e.,31 bp sequence containing TTTAAA box; see Fig. 4C) to
regulate DSP–PP transcription. In transgenic mice, the420 bp
rat promoter (see Fig. 4A) was sufficient to drive specific but
weak LacZ expression in odontoblasts only. However, the 2.4
kb mouse promoter (see Fig. 4A) drove strong LacZ activity in
both odontoblasts and ameloblasts. These data suggest that
additional cis-regulatory module(s) containing enhancer ele-
ment(s) in the 2.4 kb mouse promoter interact with the 420
bp Y 31 bp module to ensure strong DSP–PP expression.
Finally, the 5 kb rat promoter (see Fig. 4A) was able to drive
strong LacZ activity in preameloblasts and in odontoblasts and
do so with correct temporal and spatial expression patterns. It is
certainly possible that additional cis-regulatory modules located
between5 kb and2.4 kb are responsible for the spatial DSP–
PP expression observed in preameloblasts. We also speculate
that different interacting cis-regulatory modules containing
Msx1 and Cbfa1 binding sites (located within the 5 kb
upstream sequence and within the 3.3 kb first intron sequence as
shown in Fig. 4B) interact synergistically and/or redundantly,
with the420 bpY31 bpmodule to control DSP–PPmRNA
expression.
Fig. 4. Diagram of potential cis-elements in the 5 kb rat DSP–PP promoter construct. (A) The alignment of three DSP–PP promoter constructs which were used
for generating transgenic mice. The 5 kb rat DSP–PP promoter is comprised of a 5 kb upstream flanking sequence, exon 1, a 3.3 kb intron 1, and a LacZ gene.
The 420 bp rat DSP–PP promoter is comprised of a 420 bp upstream flanking sequence, exon 1, a 3.3 kb intron 1 and a LacZ gene (Sreenath et al., 1999;
Yamazaki et al., 1999). The 2.4 kb mouse DSP–PP promoter is comprised of a 2.4 kb upstream flanking sequence, exon 1, a 3.2 kb intron 1, and a LacZ gene
(Sreenath et al., 1999). represents the 500 bp conserved noncoding sequence among rat, mouse, and human. (B) Potential binding sites for transcription factors
Cbfa1 and Msx1 were located within the 5 kb rat DSP–PP upstream flanking sequence and the 3.3 kb intron 1 sequence. (C) The rat 500 bp conserved
noncoding sequence. The shaded sequence represents exon 1. represents the transcription start site. ATATA box (TTTAAA) is identified at the 24 bp position.
We designate the 31 bp region as the basal promoter. CCAAT box is located at the 52 bp position. The 405 bp Y 31 bp region is designated as a cis-
regulatory module. Within this module, the potential transcription binding sites such as AP1, SP1, Msx1, GATA-1, C/EBPh, and CBP, TCF-1, Nfr1, and SRE are
underlined. Under the transcription protein binding site ACCCCCA, a down arrow signifies that this cis-element can down-regulate DSP–PP mRNA expression.
Similarly, under the CCAAT, Y box, an up arrow signifies that this CBP (i.e., CCAAT binding protein) can up-regulate DSP–PP mRNA expression. The down
arrows next to C/EBPh and Nfr1 signify that these two transcription factors down-regulate DSP–PP mRNA expression.
V. Godovikova et al. / Developmental Biology 289 (2006) 507–516514In summary, the LacZ expression profiles described in this
report strongly suggest that our 5 kb rat DSP–PP promoter
contains sufficient information to direct DSP–PP expression
both temporally and spatially in a variety of transgenic mousetissues. While much has been written about the possible roles
that DSP and PP play in dentin mineralization, their presence in
bone and kidney for example implies that they may also play
pivotal roles in bone mineralization as well as in kidney
V. Godovikova et al. / Developmental Biology 289 (2006) 507–516 515development and function. The ability of a rat promoter to
drive DSP–PP expression in mouse tissues according to the rat
developmental time clock also provides a novel system with
which to investigate and identify temporal cis-regulatory
modules. Further studies designed to unlock the complex
DSP–PP gene regulatory network are currently being pursued.
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